ExpreS2ion Biotech Holding AB's market cap is currently ―. The company's EPS TTM is €-1.819; its P/E ratio is ―; ExpreS2ion Biotech Holding AB is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 833.00K	$ 1.25M	$ 2.03M	$ 3.40M	$ 2.55M
Gross Profit	$ -820.00K	$ 99.00K	$ 1.08M	$ 2.23M	$ 2.48M
EBIT	$ -31.45M	$ -26.41M	$ -14.64M	$ -15.98M	$ -9.82M
EBITDA	$ -31.13M	$ -26.10M	$ -14.33M	$ -15.66M	$ -9.51M
Net Income Common Stockholders	$ -30.70M	$ -25.54M	$ -13.84M	$ -14.32M	$ -9.38M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 149.56M	$ 167.72M	$ 124.68M	$ 138.88M	$ 142.00M
Total Assets	$ 170.50M	$ 188.48M	$ 140.03M	$ 151.96M	$ 159.43M
Total Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Net Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Total Liabilities	$ 21.62M	$ 14.30M	$ 8.71M	$ 11.61M	$ 13.44M
Stockholders Equity	$ 148.87M	$ 174.18M	$ 131.33M	$ 140.35M	$ 145.99M
Cash Flow	-
Free Cash Flow	$ -23.43M	$ -21.70M	$ -15.25M	$ -4.31M	$ -7.16M
Operating Cash Flow	$ -23.34M	$ -21.61M	$ -15.23M	$ -4.31M	$ -6.96M
Investing Cash Flow	$ 403.00K	$ 86.12M	$ 17.96M	$ -100.93M	$ -157.00K
Financing Cash Flow	$ 2.35M	$ 60.27M	$ -603.00K	$ -503.00K	$ 40.33M

Currency in USD

ExpreS2ion Biotech Holding AB Earnings and Revenue History

Income Statement >

ExpreS2ion Biotech Holding AB Debt to Assets

Balance Sheet >

ExpreS2ion Biotech Holding AB Cash Flow

Cash Flow >

ExpreS2ion Biotech Holding AB Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing